Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Gruppo Italiano Malattie EMatologiche dell'Adulto
Shanghai Jiao Tong University School of Medicine
University of Iowa
University of Milano Bicocca
Tata Memorial Centre
Attikon Hospital
University Hospital Schleswig-Holstein
M.D. Anderson Cancer Center
University Hospital Southampton NHS Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust
Newcastle University
University Hospital, Bordeaux
University of Pittsburgh
University Hospital, Linkoeping
Dana-Farber Cancer Institute
Hospital Universitario Dr. Jose E. Gonzalez
University Hospital, Bordeaux
Ann & Robert H Lurie Children's Hospital of Chicago